TEK and lung carcinoma: In addition to TEK, ANGPT2 can also interact with ITGA5_ITGB1, activating the TGFB-ZEB1-GLUT3 signaling pathway, accelerating physiological activities related to glycolytic metabolism in lung cancer cells, thereby causing tumor cells to prefer glycolytic metabolic pathways and accelerating tumor development61.